Wall Drugs Offered an Incentive Stock Option Plan to Its

Multiple Choice

Wall Drugs offered an incentive stock option plan to its employees. On January 1, 2018, options were granted for 60,000 $1 par common shares. The exercise price equals the $5 market price of the common stock on the grant date. The options cannot be exercised before January 1, 2021, and expire December 31, 2022.
- Each option has a fair value of $1 based on an option pricing model. What is the entry to record the expiration of 10% of the options on December 31, 2022?

A) $\begin{array}{|l|l|l|}\hline \text { Paid-in capital\_stock options } & 6,000 & \\\hline \text { Paid-in capital\_expired stock options } & & 6,000 \\\hline\end{array}$
B) $\begin{array}{|l|l|l|}\hline \text { Paid-in capital\_stock options } & 6,000 & \\\hline \text { Retained earnings } & & 6,000 \\\hline\end{array}$
C) $\begin{array}{|l|l|l|}\hline \text { Paid-in capital-stock options } & 6,000 & \\\hline \text { Compensation expense } & & 6,000 \\\hline\end{array}$
D) $\begin{array}{|l|r|r|}\hline \text { Stock options receivable } & 30,000 & \\\hline \text { Common stock } & & 6,000 \\\hline \text { Paid-in capital\_excess of par } & & 27,000 \\\hline\end{array}$